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and Anje Cauwels1,2,4*†Abstract
Background: MAPK-activated protein kinase 2 (MK2) plays a pivotal role in the cell response to (inflammatory) stress.
Among others, MK2 is known to be involved in the regulation of cytokine mRNA metabolism and regulation of actin
cytoskeleton dynamics. Previously, MK2-deficient mice were shown to be highly resistant to LPS/D-Galactosamine-induced
hepatitis. Additionally, research in various disease models has indicated the kinase as an interesting inhibitory drug target
for various acute or chronic inflammatory diseases.
Results: We show that in striking contrast to the known resistance of MK2-deficient mice to a challenge with LPS/D-Gal, a
low dose of tumor necrosis factor (TNF) causes hyperacute mortality via an oxidative stress driven mechanism. We identified
in vivo defects in the stress fiber response in endothelial cells, which could have resulted in reduced resistance of
the endothelial barrier to deal with exposure to oxidative stress. In addition, MK2-deficient mice were found to
be more sensitive to cecal ligation and puncture-induced sepsis.
Conclusions: The capacity of the endothelial barrier to deal with inflammatory and oxidative stress is imperative
to allow a regulated immune response and maintain endothelial barrier integrity. Our results indicate that,
considering the central role of TNF in pro-inflammatory signaling, therapeutic strategies examining pharmacological
inhibition of MK2 should take potentially dangerous side effects at the level of endothelial barrier integrity into account.
Keywords: MK2, Inflammatory shock, Tumor necrosis factor, Reactive oxygen species, Actin cytoskeleton, Endothelial
permeability, Cecal ligation and punctureBackground
MAP kinase (MAPK)-activated protein kinase 2 (MK2) is
involved in very diverse cellular processes ranging from cell
migration, to reorganization of the cytoskeleton, inflamma-
tion and apoptosis. MK2 is located downstream from p38
MAPK, a major transducer of cell stress responses, such as
heat shock, bacterial lipopolysaccharide (LPS), tumor
necrosis factor (TNF) and IL-1β (reviewed in [1,2]). In
response to an inflammatory stressor such as LPS, p38 will
phosphorylate and activate a number of effectors, including
MK2. The resulting p38-MK2 complex will translocate* Correspondence: anje.cauwels@vib-ugent.be
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article, unless otherwise stated.from the nucleus to the cytoplasm, followed by MK2-
mediated phosphorylation of target proteins (reviewed in
[3]). Because of this requirement for co-translocation of
p38 and MK2, MK2-deficient mice are also partially p38
MAPK-deficient [4].
One of the better characterized MK2-mediated processes
is the post-transcriptional regulation of pro-inflammatory
cytokine production [5], including but not limited to TNF
[6], IL-6 [7,8], IFN-γ [9], and possibly IL-1β [10]. Tristetra-
prolin (TTP), an mRNA-binding zinc-finger protein, destabi-
lizes many mRNAs by binding to AU-rich elements (AREs)
in their 3’ untranslated region [11], and subsequently target-
ing them to exosomes or proteasomes [12,13]. MK2
can phosphorylate TTP, thereby reducing its affinity for
the ARE [14,15] and allowing other mRNA-binding pro-
tein complexes to form that alter the dynamics of pro-d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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case of TNF mRNA translation, human antigen R (HuR)
can replace phosphorylated TTP, thereby stabilizing the
mRNA and initiating translation of TNF [16]. In addition,
the expression and post-translational regulation of TTP it-
self is also regulated by p38-MK2-dependent signal trans-
duction, which allows intrinsic feedback control of the
inflammatory response [15,16]. As a result of the depend-
ency of many pro-inflammatory mRNAs on MK2-mediated
stabilization, the expression of these cytokines in response
to many inflammatory challenges is severely altered in
MK2-deficient mice. This was first shown for TNF bio-
synthesis in response to a combined LPS/D-Galactosamine
(D-Gal) challenge, a model of acute hepatitis [6]. Another
target of p38 MAPK is MK3. The documented functions
and expression patterns of MK2 and MK3 overlap, but
MK2 is expressed at significantly higher levels, and as-
sumed to be the dominant isoform. Consistently, TNF pro-
duction in MK3-deficient mice is comparable to wild type,
while expression in MK2/MK3 double-knockout mice was
reduced further compared to MK2-deficient mice [17].
A second major p38/MK2-mediated function is the
regulation of actin cytoskeleton dynamics through phos-
phorylation of the small heat shock protein (sHSP) 25
(mouse equivalent to human sHSP27) [1,18]. The actin
cytoskeleton plays essential roles in many cellular pro-
cesses, including regulation of cell shape, endocytosis,
anchorage to cells and substrates, and signal transduc-
tion. Because of the ability of sHSPs to exist in various
states of oligomerization, depending on their phosphor-
ylation status, they can be involved in highly diverse cel-
lular functions, including molecular chaperoning [19],
modulation of the glutathione redox status [20], and
regulation of actin polymerization dynamics [21].
The endothelial cell layer plays a pivotal role in the
inflammatory response by regulating the passage of leuko-
cytes and various signaling molecules, and is an important
signal transduction interface. Put differently, its main
function is to maintain a highly specialized and select-
ive barrier between the blood and other tissues. During
systemic inflammatory conditions, endothelial cells can
become exposed to extremely high levels of inflamma-
tory mediators, such as reactive oxygen species (ROS).
When ROS-induced damage reaches critical levels or
cannot be dealt with appropriately, the barrier function
can become severely impaired, resulting in uncontrolled
fluid leak, a dysregulated immune response, cell death, and
tissue damage. Therefore, endothelial cells have evolved
mechanisms to quickly reorganize their actin cytoskeleton
into stress fibers that serve both as a contraction scaffold
to allow a controlled increase in endothelial permeability
and extravasation of leukocytes [22,23], as well as firmly
anchor the cells to their neighbors and the matrix to pre-
serve overall barrier integrity [24-26].In the current study, we examined MK2-deficiency in a
model of TNF or LPS-induced systemic inflammation, as
well as cecal ligation and puncture (CLP)-induced sepsis.
We identified profound and hyperacute TNF-induced mor-
tality, in sharp contrast to the previously described resistance
of MK2-deficient mice to LPS/D-Gal-induced hepatitis [6]
and similar results we obtained here in an endotoxic shock
model. This hyperacute phenotype appeared to be caused by
the inability of MK2-deficient endothelial cells to mount a
proper stress fiber response, resulting in excessive fluid leak,
tissue damage and mortality. Additionally, MK2-deficient
mice were also sensitized to CLP-induced mortality.
Results
The effect of MK2-deficiency on mortality induced by
systemic inflammation or sepsis
MK2-deficient mice were originally shown to be resistant
to LPS/D-Gal [6]. However, LPS/D-Gal causes apoptosis-
dependent hepatitis and not endotoxic shock [27], as often
mentioned. In order to determine the response of MK2-
deficient animals to endotoxic shock, we administered a
high i.v. dose of LPS and found that MK2-deficiency also
confers extreme protection to LPS-induced hypothermia
and mortality (Figure 1A-B). In sharp contrast to these re-
sults, MK2-deficient mice were hypersensitive to TNF-
induced inflammatory shock (Figure 1C-D). Low to very low
doses of TNF (10 – 250 μg/kg), which in wild type (WT)
mice only induced a small and temporary drop in body
temperature, caused a very fast drop in body temperature in
MK2-deficient animals, followed by acute mortality 2–8 h
after challenge. In addition, we examined the response of
MK2-deficient animals to cecal ligation and puncture (CLP)-
induced sepsis. Similarly to TNF, MK2-deficient mice were
also sensitized to CLP-induced sepsis (Figure 1E).
Acute TNF-induced inflammatory mediators and cell
damage parameters
IL-1β and IL-6 levels were significantly increased in
MK2-deficient mice 2.5 h after TNF challenge compared
to their WT counterparts (Figure 2A-B). Of note, a high
dose of TNF (450 μg/kg) was used to also evoke a clear
inflammatory response in WT mice. Intracellular proteins
such as hexosaminidase, a lysosomal enzyme, and lactate
dehydrogenase (LDH) are indicative for cellular damage
and (necrotic) disintegration when detected systemically.
Plasma hexosaminidase was significantly increased above
baseline in MK2-deficient mice only, 2.5 h after challenge
(Figure 2C). Similarly, LDH was only significantly increased
for MK2-deficient animals (Figure 2D).
The hypersensitivity of MK2-deficient mice for TNF can be
prevented by antioxidant treatment
Circulating peroxide equivalents, a measure for total oxi-
dative stress exposure, were significantly higher in plasma
Figure 1 Effect of MK2-deficiency on morbidity and mortality in systemic inflammation and sepsis. (A-B) Body temperature and mortality
for WT (n = 3) and MK2−/− (n = 5) mice after i.v. injection of 10 mg/kg LPS. (C) Body temperature for WT (n = 5) and MK2−/− (n = 9) mice after i.v.
injection of 50 or 125 μg/kg TNF. Dose groups were pooled together because statistical comparison within one genotype revealed no differences.
(D) Mortality for WT (n = 10) and MK2−/− (n = 13) mice after i.v. injection of 10, 50, 125 or 250 μg/kg TNF. Dose groups were pooled together because
statistical comparison within one genotype revealed no differences. (E) Mortality for WT (n = 9) and MK2−/− (n = 10) mice after CLP surgery. Survival
curves of different genotypes were compared via log-rank test. ****, p≤ 0.0001; **, p≤ 0.01.
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2.5 h after injection of TNF (Figure 3A), while NOx
− levels,
a measure for total nitric oxide (NO) production, were
similarly increased from baseline for both genotypes
(Figure 3B). We treated MK2-deficient animals with
antioxidants to verify the influence of oxidative stress
in the pathophysiology of the hyperacute response. The
membrane-permeable superoxide dismutase (SOD) mi-
metic and radical scavenger tempol could significantly
protect against TNF-induced mortality as a combined
pre- and post-treatment, while the non-membrane per-
meable SOD had no effect (Figure 3C).
TNF challenged MK2-deficient animals have a defective
stress fiber response
Liver sections were stained for F-actin and 3 small ves-
sels per section were imaged. Representative examples
are shown in Figure 4A1-3. Part of the endothelial cell
sheet was manually defined as a region of interest (ROI),
followed by segmentation of the ROI in discrete actin struc-
tures. Next, a number of parameters were calculated: (1) thepercentage of F-actin positive voxels in the ROI, as a meas-
ure for the density of the actin network (Figure 4B); (2) the
number of discrete actin structures per 100 000 voxels
(Figure 4C); and (3) the total number of F-actin positive
voxels per actin structure normalized over the number of
discrete actin structures, as an estimator of the size of the
actin structures (Figure 4D). F-actin density and the num-
ber of F-actin structures were not increased from baseline
in MK2-deficient mice, in contrast to WT controls, indi-
cating a failure of the endothelial cells to mount a proper
stress fiber response (Figure 4B-C). In addition, the size of
the F-actin structures was lower in the TNF challenged
MK2-deficient animals compared to WT but this differ-
ence was not significant (Figure 4D).
TNF-induced vascular leak is much more pronounced in
MK2-deficient mice
Vascular permeability was quantified by examining ex-
travasation of FITC-dextran (4 kDa) and Evans Blue. The
latter binds albumin with high affinity, resulting in an ap-
proximate molecular weight of 70 kDa. No significant
Figure 2 IL-1β, IL-6, hexosaminidase and lactate dehydrogenase levels. (A-B) Plasma IL-1β and IL-6 levels for WT and MK2−/− mice, 2.5 h
after i.v. injection of 450 μg/kg TNF (nPBS (WT and MK2−/−) = 10, nTNF (WT) = 5, nTNF (MK2−/−) = 5). (C-D) Plasma hexosaminidase and lactate
dehydrogenase plasma levels for WT and MK2−/− mice, 2.5 h after i.v. injection of 450 μg/kg TNF. Pooled data from 2 separate experiments is shown
(nPBS (WT and MK2−/−) = 17, nTNF (WT) = 10, nTNF (MK2−/−) = 8). Comparisons were made between baseline (PBS) and TNF challenged animals (#), and
between genotypes (*) via one-way ANOVA with Sidak’s multiple comparisons test. Error bars indicate SD. ****, p≤ 0.0001; **, p≤ 0.01; *, p≤ 0.05.
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(data not shown). However, the smaller molecular weight
FITC-dextran was significantly increased from baseline in
liver, kidney and spleen of MK2-deficient mice, in contrast
to WT controls (Figure 5A-B and E). Also in the lungs,
a small increase in permeability was observed, albeit
non-significant, while no effect was observed in the
heart (Figure 5C-D).
Discussion
Our results show that TNF induces a hyperacute inflam-
matory shock phenotype in MK2-deficient mice. A lethal
TNF challenge in WT mice will cause mortality between
roughly 16–24 h post-challenge (data not shown), while
a low dose of TNF normally causes only mild and transi-
ent morbidity in healthy WT mice. However, in MK2-
deficient mice, very low doses of TNF caused hyperacute
mortality already 2–8 h post-challenge. In addition, we
corroborated earlier results that demonstrated the resist-
ance of MK2-deficient mice to LPS/D-Gal induced hepa-
titis [6,27], by showing that MK2-deficient mice are also
resistant to endotoxic shock. The resistance of MK2-
deficient mice to LPS/D-Gal has been clearly linked to
reduced stability of TNF and other mRNAs encodingpro-inflammatory cytokines, via p38 MAPK/MK2/TTP-
mediated signaling [7,8,14]. However, in our TNF model,
IL-6 and IL-1β levels in circulation were increased more
in MK2-deficient animals after the challenge, compared
to WT controls. This could indicate that the hyperacute
phenotype is caused by such a severe inflammatory re-
sponse that, despite decreased mRNA stability of pro-
inflammatory cytokines, high levels of these cytokines
could still be detected in circulation. To corroborate this
further, parameters indicative for (necrotic) cellular dis-
integration were highly increased early after TNF challenge
in MK2-deficient mice, while they were not increased from
baseline for WTcontrols that received a high dose of TNF.
We previously observed a similar hyperacute pheno-
type in WT mice after a combined challenge with TNF
and the pan-caspase inhibitor zVAD-fmk [28]. In that
case and others, ROS were found to play an important
role in the pathophysiology [28,29]. Also in the current
study, highly increased levels of radicals were detected
after challenge with TNF in the MK2-deficient animals.
Therefore, we treated these animals with the antioxi-
dants tempol or SOD. Tempol is a membrane permeable
antioxidant that dismutates superoxide catalytically and
limits Fenton-mediated hydroxyl radical formation [30].
Figure 3 Peroxide equivalents, NOx
− levels, and effect of antioxidant treatment on mortality. (A) Plasma peroxide equivalents for WT and
MK2−/− mice, 2.5 h after i.v. injection of 125 μg/kg TNF. Pooled data from 2 separate experiments is shown (nPBS (WT and MK2−/−) = 13, nTNF
(WT) = 11, nTNF (MK2−/−) = 12). (B) Plasma NOx
− levels for WT and MK2−/− mice, 2.5 h after i.v. injection of 125 μg/kg TNF. Pooled data from 2
separate experiments is shown (nPBS (WT and MK2−/−) = 12, nTNF (WT) = 7, nTNF (MK2−/−) = 9). Comparisons were made between baseline (PBS)
and TNF challenged animals (#), and between genotypes (*) via one-way ANOVA with Sidak’s multiple comparisons test. (C) Mortality for TNF
challenged MK2−/− mice after pre- and post-treatment with tempol or SOD. Survival curves of different treatment groups were compared to controls
via log-rank test (*). Error bars indicate SD. ****, p≤ 0.0001; ***, p≤ 0.001; **, p≤ 0.01; *, p≤ 0.05.
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tion of superoxide and it is not membrane permeable.
Thus, the observed difference in response could indicate
that the ability of tempol to diffuse into cells and/or its
broader spectrum antioxidant activity are key factors forpreventing the acute TNF-induced toxicity. In any case,
it indicates that ROS are an important driver of the
TNF-induced pathophysiology in the absence of MK2.
The small heat shock protein 25 (sHSP25) can form
large oligomers that are known to be involved in the
Figure 4 Assessment of cytoskeletal integrity via quantification of F-actin structures and density in liver endothelial cells. (A)
Representative liver z-stacks stained for F-actin (green) and DAPI (blue), with a focus on the endothelial cell lining of a small vessel for WT and
MK2−/− mice, 2.5 h after i.v. injection of PBS or 450 μg/kg TNF; (nPBS (WT and MK2−/−) = 10 × 3 vessels/animal, nTNF (WT) = 5 × 3, nTNF (MK2−/−) = 5
× 3). For every vessel, part of the endothelial cell sheet was defined as region of interest (ROI). (B) Actin density, expressed as the percentage of
F-actin positive voxels per ROI. (C) The number of segmented F-actin positive structures per 100 000 voxels. (D) The average size of the actin
structures, expressed as the total number of F-actin positive voxels per actin structure, normalized over the number of discrete actin structures.
Comparisons were made between baseline (PBS) and TNF challenged animals (#), and between genotypes (*) via one-way ANOVA with Sidak’s
multiple comparisons test. Error bars indicate SD. *, p≤ 0.05.
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and help keep GSH in its reduced form under conditions
of oxidative stress [20,31], in addition to their well-known
protein chaperoning functions [32]. It is therefore tempt-
ing to speculate that the absence of MK2, which can
modulate the function of sHSP25 via phosphorylation,
could be the cause of the high ROS levels, resulting in tis-
sue damage and the observed acute mortality. However,
upon MK2-mediated phosphorylation the large sHSP25
oligomers dissociate into smaller oligomers and mono-
mers [33,34], and the antioxidant capacity of sHSP25 has
been clearly linked to its unphosphorylated oligomerized
form [31]. Decreased sHSP25-mediated antioxidant cap-
acity is therefore unlikely to be a dominant mechanism in
the current model.
Next, we examined actin cytoskeleton dynamics, an-
other target of MK2 via phosphorylation of sHSP25. As
mentioned earlier, large sHSP25 oligomers will dissociate
into smaller oligomers and monomers upon phosphoryl-
ation [33,34]. Considering that signal transduction occurs
through the stress-activated p38 MAPK/MK2 pathway,
phosphorylation of sHSP25 will be induced by exposure
to inflammatory mediators such as TNF and ROS. The
resulting small phosphorylated sHSP25 oligomers can
bind to F-actin filaments, thereby promoting increased
F-actin dynamics and stress fiber formation [21], manifestedby rapid reorganization of cortically localized F-actin into
long transcytoplasmic fibers [35-37]. In HUVEC cells, this
process was shown to be severely impaired after pharmaco-
logical inhibition of p38 MAPK [38]. Because of its unique
location, the endothelial actin cytoskeleton is one of the
earliest targets of ROS-mediated toxicity during an inflam-
matory response. In fact, it has been suggested that endothe-
lial barrier function, which hinges on the integrity of the
cytoskeleton, could be the limiting factor determining the
capacity of endothelial cells to deal with oxidative stress [35].
The change in F-actin dynamics serves two main functions
in the endothelium: (1) modulation of intercellular contacts
[39], as well as providing a scaffold for actomyosin-based
contractility to allow cell rounding and inter-endothelial gap
formation [40], required for the regulated extravasation of
leukocytes in response to inflammatory mediators; and (2)
firmly anchor the cells to their neighbors by connecting
intracellular stress fiber networks together through so-called
discontinuous adherens junctions to preserve barrier func-
tion in response to stress [25,26]. Our in vivo results con-
firmed that the endothelial cell barrier in MK2-deficient liver
vessels appeared to be unable to mount a proper stress fiber
response, as evidenced by the absence of increased actin
density and changes in the observable actin structures after
TNF challenge. The failure of endothelial cells to respond
appropriately to inflammatory mediators, such as TNF and
Figure 5 Vascular permeability assessed by extravasation of FITC-Dextran (4 kDa). FITC-Dextran quantification for WT and MK2−/− mice,
2.5 h after i.v. injection of 450 μg/kg TNF for liver (A), kidney (B), lung (C), heart (D), and spleen (E); (n = 5 × 2 for liver, kidney and lungs; n = 5 for
heart and spleen). Comparisons were made between baseline (PBS) and TNF challenged animals (#), and between genotypes (*) via one-way
ANOVA with Sidak’s multiple comparisons test. Error bars indicate SD. ***, p≤ 0.001; **, p≤ 0.01; *, p≤ 0.05.
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rity because of cellular damage, and excessive fluid leak,
which we observed in the liver, kidneys and spleen, culminat-
ing into end-organ failure and hyperacute mortality. The
speed of these events was further emphasized by the pro-
nounced drop in body temperature, starting as early as
90–120 min after TNF challenge, indicative for microcir-
culatory failure of end-organs. Curiously, we only ob-
served increased permeability for a 4 kDa tracer, while no
increased albumin (70 kDa) permeability was observed.
This suggests that the failure of endothelial cells to re-
organize their actin cytoskeleton appeared to result mainly
in increased permeability for fluid and small solutes, while
uncontrolled passage of larger molecules did not occur.Contrary to our results, an earlier study reported de-
creased lung endothelial permeability for Evans Blue in an
ovalbumin-induced asthma model [41], indicating that the
response of stress-induced regulation of the cytoskeleton
is highly dependent on the initial stressor and the dynam-
ics of the model.
In order to extend our results to a more clinically rele-
vant model of sepsis, MK2-deficient mice were subjected
to CLP surgery. Also CLP-induced mortality was exacer-
bated in MK2-deficient mice. The reason for this in-
creased sensitivity remains to be determined, but similar
mechanisms as described for the TNF model could be
involved. In addition, blocking TNF in CLP is known to
actually exacerbate mortality [42]. Thus, reduced TNF
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stability of pro-inflammatory cytokine mRNAs could
also have contributed to increased mortality.Conclusions
In summary, we showed that MK2-deficient mice are
highly sensitized to even very low doses of TNF, leading
to hyperacute mortality. ROS play an important role in
this pathophysiology since the phenotype could be res-
cued by antioxidant treatment with tempol. In addition,
the failure of endothelial cells to respond to ROS-induced
toxicity with an appropriate stress fiber response, required
to preserve barrier function and efficiently regulate the
immune response, appeared to be involved in the pheno-
type. In turn, this could have led to massive edema forma-
tion, increased cellular and tissue damage, and mortality.
Our results thus corroborate the dependency of actin
cytoskeletal dynamics on the stress-induced p38 MAPK/
MK2 pathway in an in vivo setting, and emphasize the im-
portance of this pathway for stabilizing the endothelial
barrier under conditions of oxidative stress. Multiple stud-
ies have highlighted the inflammation-driving role of MK2
and MK3 (reviewed in [43]) by showing that mice defi-
cient for one or more of these kinases are protected
against diverse inflammatory conditions, including arth-
ritis, pancreatitis, skin inflammation, acute proliferative
glomerulonephritis, colitis, cardiac ischemia-reperfusion
injury [44], and asthma [41] or ventilator-induced [45]
lung injury. Consequently, pharmacological inhibition of
MK proteins has been proposed as a potential therapeutic
strategy. However, our results warrant caution for the un-
bridled pharmacological targeting of MK2. Considering
the pivotal role of TNF in many acute and chronic inflam-
matory conditions, systemic inhibition of MK2 could have
potentially dangerous side effects at the level of endothe-
lial barrier integrity.Methods
Mice
MK2-deficient mice were generated on a C57BL/6J
background, as described previously [6], and bred homo-
zygously in our SPF facility. All mice were housed in
temperature-controlled, individually ventilated cages in
an SPF facility with 14/10 h light/dark cycles, food and
water ad libitum, and used at 10–20 weeks of age. All
experiments were approved by the animal ethics com-
mittee of the Faculty of Sciences of Ghent University
(Belgium), performed according to its guidelines, and
comply with Directive 2010/63/EU. For each experi-
ment, mice were monitored every 30 min for the first
6 h, followed by several times daily until recovery. Mori-
bund or surviving animals were euthanized by CO2 as-
phyxiation, followed by cervical dislocation.Reagents and injections
All reagents were dissolved in sterile phosphate buffered
saline (PBS) and 200 μl was injected intravenously (i.v.),
unless stated otherwise. Recombinant mouse TNF was
produced in and purified from Escherichia coli, LPS con-
tent was <0.02 ng/mg (chromogenic Limulus amebocyte
lysate assay), and was administered at various sublethal
doses (10, 50, 125 or 250 μg/kg) or a lethal dose
(450 μg/kg) for wild type (WT) mice. Phenol extracted
E. coli LPS (serotype O111:B4) was purchased from
Sigma (St. Louis, MO) and injected i.v. at 10 mg/kg.
Tempol (Sigma) was injected intraperitoneally (i.p.) at
285 mg/kg (−45 min) and 125 mg/kg (+2.5 h). Super-
oxide dismutase (SOD, ICN, Aurora, OH) was injected
i.p. at 3500 U/animal (−45 min) and 1800 U/animal
(+2.5 h). 0.2% Evans blue (Sigma) and 50 mg/ml FITC-
dextran (4 kDa, Sigma) were used to examine vascular
permeability.
Cecal ligation and puncture surgery
The CLP procedure was performed as described earlier
[46]. Briefly, the mice were anesthetized using 2% iso-
flurane in oxygen. After shaving and disinfecting the ab-
domen, a 10 mm midline laparotomy was performed,
followed by exposure of the cecum. Using 5–0 Ethicon
suture, the cecum was ligated immediately under the
ileocecal valve and subsequently perforated by a single
through-and-through puncture with a 22G needle. Next,
the cecum was slightly compressed until a small drop of
feces appeared. The abdomen was closed in two layers,
using 5–0 suture for the peritoneum and abdominal
musculature, and wound clips for the skin. Following
surgery, the animals were resuscitated with 1 ml 0.9% sa-
line subcutaneously. All animals were given pre- and
postoperative analgesia (Ibuprofen, 200 μg/ml in drink-
ing water), starting 24 h before until 48 h after surgery.
Mice were randomized with regard to age and genotype.
Body temperature
Rectal body temperatures were recorded on an electronic
thermometer (C28K, Comark Electronics; Littlehampton,
UK).
Vascular permeability
Animals were injected with Evans blue and FITC-dextran
30 min before dissection, followed by terminal anesthesia
with ketamine/xylazine and perfusion with 50 ml heparin
(Sigma) in sterile saline (5 mg/ml). Liver, kidneys, lungs,
heart and spleen were dissected, minced and incubated
for 24 h at 37°C in formamide (Sigma) to extract the
tracers. After clearance by centrifugation, Evans blue and
FITC-dextran levels were determined at 620 nm and
520 nm, respectively.
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−, peroxide, and cytokine levels
EDTA plasma was prepared from blood collected via car-
diac puncture after terminal anesthesia with ketamine/
xylazine and immediately flash frozen in liquid nitrogen.
Plasma concentrations of NO2
− and NO3
− (collectively
NOx
−) were determined via the Griess method as previ-
ously described [29]. Plasma peroxide equivalents were
determined with a QuantiChrom Peroxide assay (DIOX-
250, BioAssay Systems, CA) as per the manufacturer’s in-
structions. IL-1β and IL-6 levels were determined with a
Bio-Plex Pro cytokine kit (Bio-Rad, Hercules, CA), as per
the manufacturer’s instructions.
Plasma hexosaminidase and lactate dehydrogenase levels
Hexosaminidase levels were determined using p-nitrophenol-
N-acetyl-β-D-glucosamine substrate as described previously
[47]. Lactate dehydrogenase levels were determined with a
CytoTox 96 assay (Promega, Madison, WI), as per the
manufacturer’s instructions.
Immunohistochemical detection of F-actin
Livers and kidneys were dissected and fixed in 4% PFA,
followed by embedding in 5% low-melting point agarose
(type VIIa, Sigma). Tissue sections of 60 μm were cut
on a vibratome, stained with phalloidin Alexa Fluor
488 (1/25, Invitrogen, Paisley, UK) for 20 min at RT,
and counterstained with DAPI nuclear staining (1/1000,
Invitrogen). Images were taken on a Zeiss LSM780 con-
focal microscope (Carl Zeiss Microscopy, Jena, Germany)
with a 100× Plan-Apochromat/1.46 oil objective. Pixel size
was 0.083 μm at an image resolution of 1024 × 1024 pixels.
DAPI was excited with a Ti:Sa Laser Mai Tai (Spectra-
Physics) at 790 nm and detected with a spectral band-
width of 415–494 nm by the PMT. Alexa fluor 488 was
excited using the 488 line of a Multi-Argon laser and de-
tected with a spectral bandwidth of 499–587 nm by the
Quasar detection unit. The pinhole was set at 1 Airy Unit.
80 z-sections were made with 0.34 μm z-spacing. 3D seg-
mentation was performed using Volocity™ software, ver-
sion 6.1.5 (PerkinElmer Inc., Waltham, MA). Objects were
identified in a manually defined region of interest. Inten-
sity threshold was set at 38.5% and objects smaller than
0.01 μm3 were discarded. For each region of interest the
total number and volume of phalloidin-positive structures
were determined. The number of objects per unit of vol-
ume was derived from these data, and the average size of
the detected objects was calculated.
Statistical analysis
Statistical analysis was performed with GraphPad Prism
6.03 (GraphPad Software, La Jolla, CA (USA)). Survival
results were compared to each other using a log-rank
(Mantel-Cox) test. For ex vivo analysis, WT were com-
pared to MK2-deficient animals via one-way ANOVA withSidak’s multiple comparisons test. Control (PBS) groups
for both genetic backgrounds were pooled because they
were statistically similar. Values are means ± SD.
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